Executive Director of Industry & Wealth
Greater Manchester Academic Health Science Network
Linda has served as Chief Operating Officer at Manchester Academic Health Science Centre (MAHSC) from its initiation in 2009 and became Business Development Director in 2013 when MAHSC expanded but is currently covering the Chief Operating Officer again as well. MAHSC was one of only five in the UK designated by the UK Government’s Department of Health in March 2009 and, following another national competition, has recently been accredited for a further five years. MAHSC is a federated partnership, enabled by a company limited by guarantee, between University of Manchester, three major tertiary care NHS Foundation Trusts, two specialist NHS Trusts and a Clinical Commissioning Group (CCG) which also represents the other CCGs in Greater Manchester.
Within these complementary roles, Linda provides leadership in business development, economic development and industry relations across the partnerships. In this capacity she is a member of the operations executive of the NIHR Greater Manchester Comprehensive Local Research Network, the Manchester Innovation Group (Local Enterprise Partnership), and the Manchester M-health Steering Committee. She is also Chair of the ‘Health is Our Business’ Group which supports economic development in the city region via the biomedical sector.
Prior to joining MAHSC in 2009, Linda was Biotechnology Sector Director and established Bionow®, the biomedical cluster supporting economic development for the North West Development Agency (NWDA). Before this she was co-founder and General Manager of Manchester Biotech Ltd, the UK’s first dedicated biotechnology incubator company, at the University of Manchester (now part of UMI3). She also developed and directed the £35M National Biomanufacturing Centre project while at the NWDA, now managed commercially by Eden Biodesign (Actavis).
Following a PhD in Medical Biochemistry at the University of Southampton, Linda worked for a US healthcare company Pall Biomedical in technical and marketing management positions.
She was awarded an OBE in the Queen’s Birthday Honours 2009 for services to biotechnology.